Cara Therapeutics | Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
Assertio Holdings USD 166.78M 34.25M 2025-09
Cara Therapeutics USD 10.68M 9.48M 2025-06
Cassava Sciences USD 48.05M 716K 2025-09
Chugai Pharma JPY 411.08B 143.65B 2025-12
Cipla INR 62.97B 8.13B 2025-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 20.28M 300K 2025-09
CSL USD 4.61B 207M 2025-12
Grifols EUR 2.53B 182.67M 2025-09
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
J&J USD 54.13B 3.26B 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Pacira USD 120.59M 13.51M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
RedHill Biopharma USD 22.29M 64K 2025-06
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12


Cara Therapeutics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.